22 results about "Injectable Product" patented technology

1. The name of the design product: blister box (injection bottle). 2. The use of the design product: blister box for product packaging protection. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view 1.

The techniques described herein relate to computerized methods and apparatus for determining a dose injected into a user by one or more medication delivery devices. Data is accessed that is indicative of an injection event group that includes one or more injection events associated with one or more medication delivery devices. The injection event group is processed to determine the dose injected into the user based on one or more of whether the injection event is associated with a medication delivery device change, a dose size of one or more of the injection events, a position of one or more of the injection events in the injection event group, and / or a time period between one or more injection events to a next injection event in the injection event group.

The application belongs to the technical field of injection production and provides an injection filling equipment, which comprises a filling machine body, a plurality of filling pipes are arranged in the filling machine body, a liquid inlet channel and a negative pressure channel are arranged on the top of the filling pipe, a conversion assembly is further arranged on the top of the filling pipe, the liquid inlet channel is communicated with the inside of the filling pipe when the conversion assembly is in a first state, the negative pressure channel is communicated with the inside of the filling pipe when the conversion assembly is in a second state, a conveying assembly is arranged in the filling machine body, first and second fixing seats are arranged on the two sides of the conveying belt, a clamping piece is arranged between the second fixing seat and the first fixing seat, the clamping piece is used for clamping the filling bottles, a blocking piece is arranged on the first fixing seat, and the blocking piece is used for blocking a certain number of filling bottles between the clamping pieces. The application can avoid the situation that the injection liquid drips from the filling pipe and can ensure that the filling pipe is inserted into the filling bottle in advance and the filling bottle and the filling head are relatively stationary.

This invention relates to the field of auto-injector technology and discloses a fully automatic intelligent high-pressure needleless injector, comprising a main body, a needleless injection head detachably mounted on the injection end of the main body, a gripping drive assembly disposed in the middle of the inner cavity of the main body, and an impact assembly connected to the gripping drive assembly disposed in the inner cavity of the main body at the end away from the needleless injection head, and a charging assembly disposed on the inner cavity and outer end of the main body on the same side as the impact assembly; the invention, by providing a gripping drive assembly and an impact assembly, facilitates users to set the required drug injection volume and injection pressure parameters via a mobile APP, and transmits the information to the injector's control module via Bluetooth communication. The control module analyzes the received injection volume and injection pressure parameters and realizes an intelligent integrated control process for automatic drug replenishment and automatic injection of the needleless injector, improving the control capability of drug injection dosage and force.

The utility model discloses a kind of auxiliary injection devices for livestock veterinarian vaccine, including first arc plate, the first arc plate rotationally connected with second arc plate, reset mechanism is equipped between the first arc plate and second arc plate, the one end of the first arc plate close to second arc plate is fixedly connected with fixed arc plate, multiple sockets are passed through and are equipped on the fixed arc plate, and one of the socket is inserted with plug rod, the end of the plug rod is fixedly connected with adsorption block, the one end of the second arc plate away from first arc plate is fixedly connected with piston cylinder, piston is arranged in the piston cylinder and is sealingly slidably connected with it, the lateral wall of the piston is fixedly connected with connecting rod. The utility model inserts plug rod and adsorption block into different sockets, realizes the adjustment of vaccine injection dose, and vaccine injection quantity is equal each time, and the precision of vaccine injection is high.

This utility model discloses an auxiliary device for inspecting carbide deposits in ampoule-packaged injectable solutions, relating to the field of ampoule inspection technology. It includes a base and a rotatable lifting column connected to the base. A tray is connected above the lifting column, and the ampoule containers are placed on the tray. The ampoules are positioned by at least two sets of clamping members above the tray, which can move towards the center of the tray. This design uses the lifting column to adjust the height of the tray, facilitating the movement of the ampoules to a suitable light source. Rotating the tray allows for centralized inspection of the ampoules, ensuring the accuracy of carbide inspection. This significantly reduces the labor intensity of operators and effectively shortens operation time.

The present invention relates to an injectable formulation, a method for treating a metabolic disease and an administration device. The injectable formulation comprises a lipid matrix composition, a specific amount of a GLP-1 receptor agonist and at least one pharmaceutically acceptable ion. Accordingly, upon contacting an aqueous fluid, the injectable formulation forms a depot exhibiting an extended release of the GLP-1 receptor agonist in vivo or in vitro. In the method for treating the metabolic disease, the injectable formulation can be administered to a subject with a reduced dosing frequency, and it is not necessary to store the injectable formulation for the next administration. For the administration device, the injectable formulation is filled in a vial, a pre-filled syringe or a pre-filled cartridge. Therefore, the injectable formulation can be designed for a single use, thereby enhancing convenience, compliance and adherence of a subject.

1. Name of the product in this design: Dosage indicator of a syringe. 2. Purpose of this design: The syringe is used to inject drugs, etc., and belongs to medical devices; the protected part is used to indicate the injection dosage of drugs, etc. 3. The key design features of this product are the shape of the part to be protected. 4. The picture or photo that best illustrates the key design points: Design 1 front view. 5. Design 1 is designated as the basic design. 6. Other situations requiring explanation: In the view, the parts indicated by solid lines require protection, while the parts indicated by dashed lines do not require protection.

The present application relates to the technical field of bendable injection needle, and discloses a bendable injection needle with a quantitative injection device, which comprises an injection mechanism, a quantitative injection mechanism and a fixed handle. The quantitative injection mechanism comprises a quantitative component, a back-movement prevention component and a uniform speed resetting component. The quantitative component can accurately control the preset injection dose, avoiding the dose deviation problem in manual injection. The back-movement prevention component can effectively prevent the back movement of the piston during the injection process. The uniform speed resetting component and the back-movement prevention component work together to automatically reset the piston after the back-movement prevention function is released.

An insulin pump control method and apparatus, an artificial pancreatic closed-loop system, and a storage medium are provided. The method includes: acquiring first monitoring data of a target object, obtaining an injection dosage of a first injection according to a target model and the first monitoring data, and injecting the target object based on the injection dosage of the first injection. The target model is adjusted based on total dosages corresponding to historical prediction failures.

An insulin pump control method and apparatus, an artificial pancreatic closed-loop system, and a storage medium are provided. The method includes: acquiring first monitoring data of a target object, obtaining an injection dosage of a first injection according to a target model and the first monitoring data, and injecting the target object based on the injection dosage of the first injection. The target model is adjusted based on total dosages corresponding to historical prediction failures.

This application relates to the field of conveying mechanism technology and discloses a tray conveying mechanism for injection boxes, including a conveyor belt assembly and a lateral adjustment assembly. This tray conveying mechanism for injection boxes uses a dual-axis motor to drive two first bevel gears to rotate synchronously, which in turn drives a second bevel gear and a first lead screw to rotate, causing the moving plate to rise and fall precisely along the guide post, thus achieving vertical position adjustment of the guide rail side plate. In the lateral adjustment assembly, a servo motor drives two second sprockets to rotate via two chains, which in turn drives two second lead screws to rotate synchronously. This causes two corresponding connecting sleeves to push the guide rail side plate to slide laterally along the limiting post, completing the horizontal spacing adjustment. The synergistic effect of vertical and lateral adjustments allows the guide rail side plate to be flexibly positioned in multiple dimensions, ensuring precise alignment between the tray groove and the injection bottle, reducing assembly errors. It is also compatible with various tray sizes, significantly improving production flexibility and efficiency, making it more practical.

The utility model relates to a kind of concentration device for small volume injection production, including stirring tank, the surface and inside of stirring tank are provided with the stirring assembly for the stirring of injection medicament and the linkage assembly of promoting stirring uniformity;Linkage assembly includes: fixed frame, the bottom of fixed frame is slidably connected with slide bar;Bump, bump is arranged in slide bar, and the bottom of bump is fixed in the top of gear two;Gear two is driven by stirring assembly;Slide bar, the surface of slide bar is fixed with rack one;Rack one, rack one is used to drive the movement of movable element arranged in stirring tank;Movable element, movable element is used to inwardly gather injection medicament.Through the stirring assembly of setting and mixing work to raw material, simultaneously drive linkage assembly by stirring assembly, realize the reciprocating movement of spoiler, so that injection medicament can be inwardly gathered due to centrifugal force, improve stirring efficiency, avoid the situation of uneven stirring occurs, to ensure the product quality and stability of injection.

An injection syringe for injecting a first injectable product into a body injection site of an individual, includes a first barrel containing a first product, a first syringe barrel containing the first injectable product, a first plunger displaceably mounted in the first syringe barrel; a hollow needle to be inserted into the body injection site; an adapter connected to the first syringe barrel and the needle, and a verification device to ensure that, when the first injectable product is injected, the hollow needle is not introduced into a blood vessel. The verification device includes a second syringe barrel containing a second product and connected to the adapter and a second plunger displaceably mounted in the second syringe barrel to cause a depression at the distal end of the hollow needle.

The present application belongs to the technical field of aluminum salt determination of injection products in the pharmaceutical industry, and particularly relates to a method for determining aluminum salt in peritoneal dialysis fluid by using a fluorescence spectrophotometer. 3+ The complex formed in ethyl acetate has good stability and strong fluorescence intensity, and the sample is treated with concentrated hydrochloric acid and extracted with 1,1-dimethylpropanone (MIPK for short), so that the interference of transition metal impurity ions is eliminated. At the same time, the special determination parameters are specified, and the method after the research is verified well, and meets the aluminum salt inspection of peritoneal dialysis fluid products.

A method for performing liquid chromatography includes receiving, by a receptor of a liquid chromatography sample manager, an original capped vial containing an injectable substance, processing, by an automated system of the liquid chromatography sample manager without human intervention, the injectable substance, and injecting, by the automated system of the liquid chromatography sample manager without human intervention, the injectable substance into a chromatographic flow for analysis. A liquid chromatography sample manager includes an automated system configured to, without human intervention, process the injectable substance; and inject the injectable substance into a chromatographic flow for analysis.

The present disclosure provides a formulation of human pluripotent stem cell-derived islets, which is capable of maintaining the structure and biological activity of the human pluripotent stem cell-derived islets during transportation; and said formulation could be used in the manufacture of injections, the final product of injections meets the requirements including sterility, apyrogenicity, safety and stability.

This invention relates to a sustained-release injectable composition containing exenatide and its preparation method. Using this sustained-release injectable composition, exenatide can be continuously released in vivo for 1 to 2 months with a single injection, thereby reducing the frequency of administration and improving convenience. Furthermore, by encapsulating exenatide in uniformly sized microparticles, a prolonged sustained release of exenatide is achieved, resulting in improved bioavailability compared to existing exenatide injectable formulations.

This application provides a needle-free microfluidic injection device, relating to the field of needle-free injection technology. The needle-free microfluidic injection device includes a main body, a laser generator, and a nozzle. The main body has a pressure generating chamber and a liquid storage chamber arranged sequentially along its height. The pressure generating chamber holds a pressurized liquid, and the liquid storage chamber holds an injection solution. A first elastic membrane is provided at the bottom of the pressure generating chamber to seal its bottom, and a second elastic membrane is provided at the top of the liquid storage chamber to seal its top. The surfaces of the first and second elastic membranes are connected by a connecting plate. The laser generator generates laser light to react with the pressurized liquid and generate energy. The nozzle is installed at the bottom of the main body, and its interior communicates with the liquid storage chamber. The nozzle is used to eject the injection solution from the liquid storage chamber. It exhibits good stability and can improve the problem of large differences in injection dosage.

The present invention provides a composition for in situ implants comprising a biodegradable first polymer, pH responsive second polymer, one or more organic solvents and a viscosity modifying vehicle. The present invention also provides a composition for an in situ implant, the composition comprising a first polymer, said first polymer being biodegradable, a second polymer, said second polymer being able to form an inclusion complex with one or more pharmaceutically active ingredients (APIs), one or more polar organic solvents, and a viscosity modifying vehicle. Injectables comprising said compositions are also described. The compositions and injectables can be used as a sustained-release dosage form of a pharmaceutical substance in therapeutic applications.

1. Name of the product in this design: Lower middle part of a syringe. 2. Purpose of this design: The syringe is used to inject drugs, etc., and belongs to medical devices; the protected part is used to adhere labels, indicate the injection dosage of drugs, etc. 3. The key design features of this product are the shape and pattern of the part to be protected. 4. The picture or photo that best illustrates the key design points: Design 1 front view. 5. Design 1 is designated as the basic design. 6. Other situations requiring explanation: In the view, the parts indicated by solid lines require protection, while the parts indicated by dashed lines do not require protection.